| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $2.98 ▼ -0.69% | Yesterday | $3.01 ▲ +0.29% | Tomorrow's Cyclerion Therapeutics Inc. Common Stock (CYCN) setup is anchored to $3.00 and targets $2.98 (-0.69%). The near-term read is downside; watch $3.09 / $2.91 because daily realized volatility is about 3.57%. |
Tomorrow's Cyclerion Therapeutics Inc. Common Stock (CYCN) setup is anchored to $3.00 and targets $2.98 (-0.69%). The near-term read is downside; watch $3.09 / $2.91 because daily realized volatility is about 3.57%. | ||||
| Week | $2.94 ▼ -2.16% | Last Week | $3.03 ▲ +0.91% | The 7-day Cyclerion Therapeutics Inc. Common Stock model moves from $3.03 to $2.94 (-2.16%). It gives downside momentum context for this stock, so breaks around $3.09 / $2.91 matter more than a single tick. |
The 7-day Cyclerion Therapeutics Inc. Common Stock model moves from $3.03 to $2.94 (-2.16%). It gives downside momentum context for this stock, so breaks around $3.09 / $2.91 matter more than a single tick. | ||||
| Month | $2.86 ▼ -4.59% | Last Month | $3.06 ▲ +1.93% | The 1-month Cyclerion Therapeutics Inc. Common Stock target is $2.86 (-4.59%), compared with the live reference near $3.00. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Cyclerion Therapeutics Inc. Common Stock target is $2.86 (-4.59%), compared with the live reference near $3.00. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $2.75 ▼ -8.24% | Last Year | $3.10 ▲ +3.46% | The 1-year Cyclerion Therapeutics Inc. Common Stock scenario points to $2.75 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Cyclerion Therapeutics Inc. Common Stock scenario points to $2.75 (-8.24%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $2.50 ▼ -16.80% | 5 Years Ago | $3.21 ▲ +7.06% | The 5-year Cyclerion Therapeutics Inc. Common Stock view is $2.50 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Cyclerion Therapeutics Inc. Common Stock view is $2.50 (-16.80%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $3.00 | Mid |
| Daily Change | 0.00% | Mid |
| Volatility Cap | 20.0% | Mid |
| Confidence | 57% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $3.00 | Daily Change | 0.00% |
| Market Cap | $12.99M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.